BioSpace News Archive

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Ildong Pharmaceutical, today announced an agreement under which Ildong will license a suite of Twist VHH antibody libraries to use to discover and develop antibodies for applications in immuno-oncology.

Zoetis Inc . (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, Aug. 4, 2022.

Simulations Plus Hosts 2nd Annual Pharmacometrics Workshop.

Evofem Biosciences, Inc., (Nasdaq: EVFM) announced today that the United States Patent and Trademark Office (USPTO) issued to the Company a Notice of Allowance for patent application 16/738,868 entitled, “Compositions and Methods for Enhancing the Efficacy of Contraceptive Microbicides.”

The latest market analysis report published by Reports and Data, titled ‘Global Life Science Analytics Market – Forecast to 2027,’ thoroughly examines the Life Science Analytics industry to provide essential data & information for the targeted readers

The latest market analysis report published by Reports and Data, titled ‘Global Prefilled Syringes Market – Forecast to 2027,’ thoroughly examines the Prefilled Syringes industry to provide essential data & information for the targeted readers.

Quest Analytics, the leader in provider network management solutions and services, today introduced three new features for Quest Enterprise Services (QES) designed to improve their client’s ability to address the No Surprises Act (NSA) and the evolving provider network regulations.

The “Healthcare and Medical System Integrators Market Growth (Status and Outlook)” Study has been added to Data Bridge Market Research’s repository.

Active Implantable Medical Devices Market research report, comprehensive analysis of the market structure along with forecast of the various segments and sub-segments of the Healthcare industry can be obtained.

Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that it has executed an agreement to terminate the U.S. and ex-U.S. vadadustat Collaboration and License Agreements with Otsuka Pharmaceutical Co., Ltd. (Otsuka).